Article Text

Download PDFPDF
Reminder of important clinical lesson
An unusual case of systemic cardiovascular side effects from the application of over-the-counter nasal decongestion drops
  1. Matthew G Browning1,
  2. James O Seddon2,
  3. Lisa T M Yung3,
  4. Gemma Gough4
  1. 1Emergency Department, Torbay Hospital, Torquay, UK
  2. 2Department of Medicine, Warwick Medical School, The University of Warwick, Coventry, West Midlands, UK
  3. 3Department of Cardiology, Royal Cornwall Hospital, Treliske, Truro, UK
  4. 4Department of Paediatrics, The Great Western Hospital, Swindon, UK
  1. Correspondence to Matthew G Browning, browningmg{at}gmail.com

Summary

A 78-year-old female with a history of stable angina, phoned for advice with chest pains following the application of 0.5% ephedrine nasal drops for nasal congestion, which she had bought over-the-counter on the recommendation of a pharmacist. On applying the medication, she developed chest pain which she recognised as her angina. The Foundation Year 2 general practitioner on duty consulted the British National Formulary (BNF), issue 56 and thought that nasal decongestant induced angina was unlikely and advised the patient to seek emergency attention should she have any further episodes. After re-applying the medication and suffering the same symptoms, the patient later presented to the Emergency Department. The patient had the relevant tests and was diagnosed with ‘ephedrine-induced angina’. This settled on withdrawal of the medication and she had no further episodes of chest pain in the following 6 months.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests None.

  • Patient consent Obtained.